A detailed history of Lantern Wealth Advisors, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Lantern Wealth Advisors, LLC holds 23,300 shares of ABCL stock, worth $66,405. This represents 0.04% of its overall portfolio holdings.

Number of Shares
23,300
Previous 23,300 -0.0%
Holding current value
$66,405
Previous $69 Million 12.16%
% of portfolio
0.04%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.73 - $4.73 $2,047 - $3,547
750 Added 3.33%
23,300 $69 Million
Q4 2023

Feb 14, 2024

BUY
$3.91 - $5.93 $88,170 - $133,721
22,550 New
22,550 $129 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $813M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Lantern Wealth Advisors, LLC Portfolio

Follow Lantern Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lantern Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lantern Wealth Advisors, LLC with notifications on news.